MX349690B - Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal. - Google Patents

Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal.

Info

Publication number
MX349690B
MX349690B MX2013004963A MX2013004963A MX349690B MX 349690 B MX349690 B MX 349690B MX 2013004963 A MX2013004963 A MX 2013004963A MX 2013004963 A MX2013004963 A MX 2013004963A MX 349690 B MX349690 B MX 349690B
Authority
MX
Mexico
Prior art keywords
peg
colorectal cancer
block copolymers
treating colorectal
treating
Prior art date
Application number
MX2013004963A
Other languages
English (en)
Other versions
MX2013004963A (es
Inventor
Cox Ian
Smith Samuel
Jones Leighton
Charlton Rachel
Stein Peter
Plessl Joerg
De Vries Corinne
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of MX2013004963A publication Critical patent/MX2013004963A/es
Publication of MX349690B publication Critical patent/MX349690B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente invención se relaciona con métodos de tratamiento y para tratamiento, para mejorar o prevenir el cáncer colorrectal (CCR) en seres humanos utilizando polietilenglicol (PEG) o un copolímero de bloque de PEG tal como Pluronic(r) F68. También se describen composiciones para usarse en el tratamiento, mejoramiento y/o prevención de CCR que comprenden PEG. Las composiciones se pueden usarse en los métodos de la invención.
MX2013004963A 2010-11-04 2011-11-04 Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal. MX349690B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
US41212810P 2010-11-10 2010-11-10
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (2)

Publication Number Publication Date
MX2013004963A MX2013004963A (es) 2013-08-27
MX349690B true MX349690B (es) 2017-08-09

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004963A MX349690B (es) 2010-11-04 2011-11-04 Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal.

Country Status (22)

Country Link
US (2) US20130216493A1 (es)
EP (1) EP2635289B1 (es)
JP (1) JP5917537B2 (es)
KR (1) KR20130109171A (es)
CN (1) CN103313719A (es)
AR (1) AR083770A1 (es)
AU (1) AU2011324996B2 (es)
BE (1) BE1019494A3 (es)
BR (1) BR112013011012A2 (es)
CA (1) CA2816839A1 (es)
EA (1) EA201300540A1 (es)
ES (1) ES2401269B1 (es)
GB (1) GB201018650D0 (es)
MX (1) MX349690B (es)
MY (1) MY163067A (es)
NL (1) NL2007715C2 (es)
NZ (1) NZ611145A (es)
SG (1) SG189533A1 (es)
TW (1) TWI606832B (es)
UA (1) UA107998C2 (es)
WO (1) WO2012059725A1 (es)
ZA (1) ZA201304052B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
KR20170098980A (ko) 2012-09-11 2017-08-30 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
TW201431556A (zh) * 2012-10-26 2014-08-16 Univ Northshore Healthsystem 用於頭部和頸部鱗狀細胞癌之療法的包含聚乙二醇之組成物
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
EP3934663A1 (en) * 2019-03-05 2022-01-12 Dow Global Technologies LLC Polyethyleneglycol derivatives for inducing caspase activity
CN113507933B (zh) * 2019-03-05 2024-05-10 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Also Published As

Publication number Publication date
CA2816839A1 (en) 2012-05-10
AU2011324996A1 (en) 2013-05-02
US20160228467A1 (en) 2016-08-11
SG189533A1 (en) 2013-05-31
TWI606832B (zh) 2017-12-01
US20130216493A1 (en) 2013-08-22
AR083770A1 (es) 2013-03-20
ZA201304052B (en) 2014-02-26
JP5917537B2 (ja) 2016-05-18
MX2013004963A (es) 2013-08-27
BE1019494A3 (fr) 2012-07-03
KR20130109171A (ko) 2013-10-07
GB201018650D0 (en) 2010-12-22
NZ611145A (en) 2015-07-31
MY163067A (en) 2017-08-15
ES2401269B1 (es) 2014-02-19
CN103313719A (zh) 2013-09-18
UA107998C2 (uk) 2015-03-10
JP2013544809A (ja) 2013-12-19
EA201300540A1 (ru) 2013-09-30
WO2012059725A8 (en) 2013-05-30
EP2635289B1 (en) 2020-03-11
WO2012059725A1 (en) 2012-05-10
BR112013011012A2 (pt) 2016-08-23
EP2635289A1 (en) 2013-09-11
NL2007715A (en) 2012-05-07
TW201304785A (zh) 2013-02-01
NL2007715C2 (en) 2012-10-16
ES2401269A1 (es) 2013-04-18
AU2011324996B2 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
IL261338B (en) Preparations and methods for the treatment of wide-ranging, undifferentiated or mixed clinical applications
HK1216880A1 (zh) 某些三唑並吡啶化合物、其組合物和它們在治療癌症中的用途
MX349827B (es) Compuestos que contienen nitrogeno y su uso.
WO2012048099A3 (en) Nanoparticle-loaded cells
MX2013004963A (es) Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal.
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
PH12015501088A1 (en) Dimeric compounds
MY162146A (en) Pharmaceutical composition
MX341348B (es) Composicion que comprende aflibercept, acido folinico, 5-fluorouracilo (5-fu) e irinocetan (folfiri).
WO2011130164A3 (en) Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer
WO2012078633A3 (en) Methods of inhibiting metastasis from cancer
WO2009095261A3 (en) Vaccine compositions
TN2012000170A1 (en) Compositions for treating centrally mediated nausea and vomiting
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
WO2012158672A3 (en) Compounds for use in treatment of mucositis
MX349948B (es) Proteínas inmunógenas y composiciones para el tratamiento y prevención de streptococcus agalactiae.
MX2013007230A (es) Sistemas de polimero.
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
WO2012073047A3 (en) Compositions and methods
MX2013004062A (es) Analogos de ciclosporina.
WO2012074725A3 (en) Immunomodulatory methods and systems for treatment and/or prevention of hypertension
WO2011100330A3 (en) Compositions and methods for preventing or treating a human parvovirus infection
PH12015500185B1 (en) Azaheterocycles as bir2 and/or bir3 inhibitors
MX344189B (es) Formulaciones de mazindol.

Legal Events

Date Code Title Description
FG Grant or registration